Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.
原文: https://www.cnbc.com/2025/11/05/wegovy-ozempic-maker-novo-nordisk-q3-earnings.html
Last Update:
5 11 月, 2025